.
MergerLinks Header Logo

Announced

OptumRx to acquire Diplomat Pharmacy for $300m.

Financials

Edit Data
Transaction Value£228m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Friendly

Single Bidder

Acquisition

Pending

United States

Pharmaceuticals

Merger

Tender Offer

Public

infusion services

Majority

Synopsis

Edit

OptumRx, the pharmacy care services business of Optum, agreed to acquire Diplomat Pharmacy, a provider of specialty pharmacy and infusion services, for c. $300m. “With its focus in specialty and infusion services, Diplomat has a proven track record of solving the unique challenges facing patients with complex health care needs. This combination will expand the innovative specialty pharmacy and infusion solutions OptumRx can offer to the consumers and clients we serve, helping ensure people get the right medications and services at the right time, in the right setting,” John Prince, OptumRx CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US